IMS March 2015. *Source: International Diabetes Federation     Monoclonal Antibodies & Recombinant Proteins   The European Medicines Agency (EMA) has accepted our partner Mylan’s Marketing Authorization Application (MAA) for our proposed biosimilar Pegfilgrastim...

More